Retrospective real-world evaluation of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in a diverse urban patient population
Latest Information Update: 31 May 2019
At a glance
- Drugs Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide (Primary) ; Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 31 May 2019 New trial record
- 16 Apr 2019 Results presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases